Insider Brief
- Novo Holdings has made a strategic investment in Quantonation II, reinforcing its commitment to advancing quantum technology for addressing societal, environmental and healthcare challenges.
- Quantonation, the world’s largest quantum technology-focused venture capital fund, has raised €112 million for its second fund, with investments in startups like Diraq and Resolve Stroke.
- The partnership aims to drive transformative quantum innovations, particularly in precision medicine, new materials, and climate change mitigation, with a focus on impactful applications in the healthcare sector.
PRESS RELEASE — Quantonation Ventures, the leading quantum technology investment fund with a global reach, is proud to announce a strategic investment from Novo Holdings in Quantonation II. This investment underscores Novo Holdings’ commitment to fostering innovation and addressing critical global challenges through advancements in science and technology. By focusing on sectors such as precision medicine, new materials, and climate change mitigation, this partnership is set to unlock new opportunities for quantum startups, driving meaningful change and transformative solutions. This investment in Quantonation II aims to accelerate the development of quantum technologies that can have transformative social and environmental impact on applications in the healthcare industry, particularly in the Nordics.
Established in 2018, Quantonation is the world’s largest venture capital fund specializing in quantum technology. It invests globally and has already deployed its first fund, Quantonation I, with AUM totaling €91 million, invested across 27 startup companies, including investments in Pasqal, a global leader in neutral atoms quantum computing, Qubit Pharmaceuticals, a quantum-aided drug discovery company, and quantum AI leader Multiverse Computing.
Quantonation is now raising and deploying its Fund II, with €112 million already raised and a €200 million target by the end of Q2 2025. Quantonation II has already invested more than €30 million in groundbreaking companies such as Diraq, Resolve Stroke, Steerlight, QBlox, Pioniq, Quantum Signals, and Tau Systems across the globe.
Novo Holdings’ investment in Quantonation II aligns with its mission to back groundbreaking technologies that address societal, environmental and healthcare-related challenges. The investment from Novo Holdings marks the launch of its investment program in quantum technologies.
Christophe Jurczak, Managing Partner of Quantonation, stated: “We are honored to welcome Novo Holdings as a strategic partner. Their vision and commitment to creating lasting social and environmental impact align perfectly with Quantonation’s mission to drive the quantum revolution. Together, we aim to empower startups in our portfolio to transform quantum innovations into tangible solutions that benefit humanity.”
The collaboration between Quantonation and Novo Holdings highlights the growing recognition of quantum technology as a pivotal tool in addressing global challenges.
